Table II.
CD4+ T Cell Subset | Head and Neck LN | MLN | ||||
---|---|---|---|---|---|---|
PBS | H647 | H696 | PBS | H647 | H696 | |
%CD25+CD4+ | 9.60 ± 0.11 | 10.38 ± 0.29 | 12.87 ± 0.58† | 10.32 ± 0.23 | 9.37 ± 0.25 | 13.73 ±0.34* |
%FoxP3+CD25+CD4+ | 9.96 ± 0.53 | 9.92 ± 1.19 | 14.96 ± 1.16† | 24.08 ± 4.82 | 21.93 ± 1.1 | 41.19 ± 2.97† |
%CD39+CD25+CD4+ | 5.34 ± 0.76 | 6.38 ± 1.32 | 2.89 ± 1.38 | 4.96 ± 0.26 | 4.74 ± 1.40 | 16.53 ± 1.89‡ |
%CD39+FoxP3+CD25+CD4+ | 14.21 ± 0.75 | 19.54 ± 2.79 | 17.54 ± 2.56 | 18.14 ± 2.06 | 13.70 ± 2.20 | 41.34 ± 2.44‡ |
%CD39+FoxP3−CD25+CD4+ | 3.83 ± 0.42 | 4.82 ± 1.43 | 2.81 ± 0.14 | 6.64 ± 0.38 | 5.67 ± 1.44 | 12.5 ± 1.88† |
%FoxP3+CD25−CD4+ | 1.30 ± 0.24 | 0.62 ± 0.08 | 1.88 ± 0.45 | 6.48 ± 0.63 | 4.89 ± 1.52 | 11.06 ± 2.5† |
%CD39+CD25−CD4+ | 2.90 ± 0.75 | 3.42 ± 0.55 | 1.40 ± 0.07 | 3.05 ± 0.52 | 2.33 ± 0.77 | 15.03 ± 1.43* |
%CD39+FoxP3+CD25−CD4+ | 9.75 ± 1.44 | 9.43 ± 1.65 | 8.41 ± 1.87 | 11.21 ± 0.95 | 8.77 ± 1.72 | 31.97 ± 2.67‡ |
%CD39+FoxP3−CD25−CD4+ | 4.1 ± 1.12 | 3.51 ± 0.89 | 1.70 ± 0.23 | 4.42 ± 0.84 | 2.67 ± 0.74 | 17.44 ± 1.27* |
%CD39+CD4+ | 1.92 ±3.16 | 3.81 ± 0.89 | 1.66 ± 0.22 | 3.02 ± 0.25 | 2.56 ± 0.61 | 16.59 ± 1.43* |
P < 0.001;
P < 0.005;
P < 0.05 as compared to PBS and H647 groups.